UK approves GSK’s Covid antibody drug that slashes risk of death and hospitalisation: It is given to patients considered most at-risk of developing severe disease, including elderly people and those with underlying health conditions.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment